vimarsana.com

Page 4 - தேசிய பல்கலைக்கழகம் புற்றுநோய் நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Singapore announces precision oncology partnership

Singapore announces precision oncology partnership Singapore announces precision oncology partnership 10 February 2021 | News Public sector partners will provide research expertise and insights to build infrastructure for data sharing, and Roche will provide access to genomic testing and guidance on infrastructure design and implementation Photo Credit: Roche Singapore Singapore Translational Cancer Consortium (STCC), National Cancer Centre Singapore (NCCS), the National University Cancer Institute, Singapore (NCIS) at the National University Hospital (NUH) and Roche announced a unique and groundbreaking partnership between public and private sector institutions in Singapore aimed at establishing a critical infrastructure to advance the adoption of personalised healthcare in Singapore. Personalised healthcare, which includes precision oncology or personalised cancer care, leverages insights from medical and genomic data to help make more precise treatment decisions

Bot MD, an AI-based chatbot for doctors, raises $5 million for expansion into more Asian markets – TechCrunch

Bot MD, an AI-based chatbot for doctors, raises $5 million for expansion into more Asian markets Time is critical for healthcare providers, especially in the middle of the pandemic. Singapore-based Bot MD helps save time with an AI-based chatbot that lets doctors look up important information from their smartphones, instead of needing to call a hospital operator or access its intranet. The startup announced today it has raised a $5 million Series A led by Monk’s Hill Ventures. Other backers include SeaX, XA Network and SG Innovate, and angel investors Yoh-Chie Lu, Jean-Luc Butel and Steve Blank. Bot MD was also part of Y Combinator’s summer 2018 batch.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.